Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden · Delayed Price · Currency is SEK 65.00
+0.10 (0.15%)
Sep 4, 2026, 1:54 PM CET
STO:IBT.B Market Cap
STO:IBT.B has a market cap or net worth of 874.3 million as of September 4, 2026. Its market cap has decreased by -14.83% in one year.
Market Cap
874.30M
Enterprise Value
765.69M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
65.00
ChartMarket Cap Chart
Since March 29, 2016, STO:IBT.B's market cap has increased from 187.49M to 874.30M, an increase of 366.31%. That is a compound annual growth rate of 15.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 875.64M | 28.71% |
| Dec 30, 2025 | 680.31M | -5.78% |
| Dec 30, 2024 | 722.07M | -40.44% |
| Dec 29, 2023 | 1.21B | 116.00% |
| Dec 30, 2022 | 561.31M | -25.15% |
| Dec 30, 2021 | 749.91M | -40.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.58B |
| Flerie AB | 1.56B |
| BioInvent International AB | 1.50B |
| Genovis AB (publ.) | 1.49B |
| Medivir AB | 1.22B |
| SynAct Pharma AB | 1.15B |
| AlzeCure Pharma AB | 1.09B |
| Oncopeptides AB | 739.19M |